‘An Australian pharmaceutical company is planning to introduce its flu vaccine in the U.S. as early as 2007, becoming the latest manufacturer to pledge increased production a year after a flu shot shortage scared the nation and led to long lines outside clinics.

CSL Limited, based in Melbourne with a subsidiary in King of Prussia, Pa., plans to file for regulatory approval early next year and hopes to offer the vaccines in time for the fall 2007 to spring 2008 flu season. The company is doubling capacity at its Australian plant to 40 million doses a year, half of which should be available for the U.S. market. ‘

Read more at Australian Co. to Enter Flu Vaccine Market

Recent Entries

• Sigma Pharmaceuticals year profit rises 27 pct
• South African citizens cheap drug guinea pigs
• Two drugs test victims face a year in coma
• Can drug companies improve their reputation?
• Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts
• Pfizer’s Forecast Disappoints
• Pharmaceutical RFID Adoption Stalls
• Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients
• GlaxoSmithKline unveils best results since merger
• Pfizer Sues Teva, Sandoz Over Zithromax

This entry was posted on Tuesday, February 7th, 2006 at 11:42 am and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.